Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients

Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients in China

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05988125

Enrollment

2000

Registered

2023-08-14

Start date

2017-01-01

Completion date

2025-03-31

Last updated

2024-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endovascular Treatment

Keywords

acute Ischemic Stroke, Endovascular Treatment

Brief summary

To investigate the real situation of assessment, diagnosis and treatment of acute ischemic stroke patients with endovascular therapy.

Detailed description

Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients is an academic,independent, pragmatic , prospective, multicenter, observational registry study. The acute ischemic stroke patients undergone endovascular therapy will be enrolled in stroke centers. Baseline information and clinical follow-up information at 90 days of stroke onset are collected. Data collected include demographics, comorbidities, pathogenesis, blood pressures, stroke severity on admission, time intervals, reperfusion condition, and functional outcome, et al. The study aims to investigate the real situation of assessment, diagnosis and treatment of acute ischemic stroke patients with endovascular therapy.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Acute ischemic stroke; 2. Brain imaging confirmed intracranial large vessel occlusion: intracranial internal carotid artery (ICA), middle cerebral artery (MCA M1/M2), anterior cerebral artery (ACA A1/A2), basilar artery (BA), vertebral artery (VA V4), and posterior cerebral artery (PCA P1); 3. Initiation of any type of endovascular treatment, including mechanical thrombectomy, aspiration, angioplasty, and stenting; 4. Informed Consent as documented by signature or fulfilling the criteria for emergency consent/ deferral consent

Exclusion criteria

1. Acute intracranial haemorrhage 2. No evidence of large vessel occlusion on digital subtraction angiography. 3. Patient bedridden or presenting from a nursing home 4. Foreseeable difficulties in follow-up due to geographic reasons (e.g. patients living abroad) -

Design outcomes

Primary

Measure	Time frame	Description
The modified Rankin Scale score at 90 days	90 days	The range of the modified Rankin Scale is from 0 to 6. A higher score indicates a worse outcome. 0-No symptoms; 1-No significant disability; 2-Slight disability; 3-Moderate disability; 4-Moderately severe disability; 5-Severe disability; 6-Dead.

Secondary

Measure	Time frame
Successful reperfusion rate	90 days
symptomatic intracranial hemorrhage or death within 90 days after stroke onset.	90 days

Countries

China

Contacts

Primary ContactWen-huo Chen, bachelor

doctorwwenhuo@126.com+86-05962082582

Outcome results